‘Greed, greed, greed’: Sanders demands Ozempic maker lower prices
While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, on Tuesday, Sen. Bernie Sanders alleged that 40,000 people a year in the US could die if the company doesn’t make the medicines more affordable.
WASHINGTON — Senate health committee chair Bernie Sanders said major drug middlemen have agreed not to limit coverage of Novo ...
The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite ...
The maker of diabetes and weight-loss drugs Ozempic and Wegovy was in the hot seat Tuesday as Vermont Sen. Bernie Sanders ...
Senators grilled Novo Nordisk CEO Lars Jorgensen at a hearing on Tuesday about the cost of diabetes drug Ozempic and weight ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback